THA improves word priming and clonidine enhances fluency and working memory in Alzheimer's disease

Neuropsychopharmacology

Volumn 20, Issue 4, 1999, Pages 357-364

  Riekkinen Jr , Paavo ^a   Riekkinen, Minna ^a  

^a KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

2 agonist; Alzheimer's disease; Cholinesterase inhibitor; Frontal functions; Semantic Priming

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; CHOLINESTERASE INHIBITOR; CLONIDINE; NEUROLEPTIC AGENT; TACRINE; UNCLASSIFIED DRUG;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BLOOD PRESSURE; CLINICAL ARTICLE; CLINICAL TRIAL; COGNITION; FEMALE; FOREBRAIN; HUMAN; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; TAKIN; WORD RECOGNITION; WORKING MEMORY;

ADRENERGIC ALPHA-AGONISTS; AGED; ALZHEIMER DISEASE; BLOOD PRESSURE; CLONIDINE; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; MEMORY, SHORT-TERM; NOOTROPIC AGENTS; PSYCHOMOTOR PERFORMANCE; TACRINE; VERBAL BEHAVIOR;

EID: 0344334032     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0893-133X(98)00093-1     Document Type: Article

References (40)

1. Alhainen K., Partanen J., Reinikainen K., Laulumaa V., Soininen H., Airaksinen M., Riekkinen P. Discrimination of tetrahydroaminoacridine responders by a single dose pharmaco-EEG in patients with Alzheimer's disease. Neurosci Lett. 127:1991;113-116. a.
2. Alhainen K, Riekkinen P Sr, Helkala E-L, Partanen J, Laulumaa V, Reinikainen K, Soininen H, Airaksinen M (1991b): The effect of THA on cognitive functions and spectral power EEG in Alzheimer's disease: preliminary results of an open study. In Iqbal K, McLachlan D, Winblad B, Wisniewski HM (eds), Alzheimer's Disease: Basic Mechanisms, Diagnosis and Therapeutic Strategies. Chichester, John Wiley & Sons, pp 611-619.
3. Arnsten A.F., Cai J.X. Postsynaptic alpha-2 receptor stimulation improves memory in aged monkeys. Indirect effects of yohimbine versus direct effects of clonidine Neurobiol Aging. 14:1993;597-603.
4. Arnsten A.F., Steere J.C., Hunt R.D. The contribution of alpha 2-noradrenergic mechanisms of prefrontal cortical cognitive function. Potential significance for attention-deficit hyperactivity disorder. Arch Gen Psychiatry. 53:1996;448-455.
5. Baddeley A. The fractionation of working memory. Proc Natl Acad Sci. 93:1996;13468-13472.
6. Baddeley A.D., Della Salla S., Spinnler H. The two-component hypothesis of memory deficit in Alzheimer's disease. J Clin Exp Neuropsychol. 13:1991;372-380.
7. Becker J.T. Working memory and secondary memory deficits in Alzheimer's disease. J Clin Exp Neuropsychol. 10:1988;739-753.
8. Borkowski J.G., Benton A.L., Spreen O. Word fluency and brain damage. Neuropsychologia. 5:1967;135-140.
9. Bowen D.M., Smith C.B., White P., Davison A.N. Neurotransmitter related enzymes and indices of hypoxia in senile dementia and other abiotrophies. Brain. 99:1976;459-496.
10. Braak H., Braak E. Evolution of the neuropathology of Alzheimer's disease. Acta Neurol Scand. 165(Suppl):1996;3-12.
11. Bunsey M., Eichenbaum H. Conservation of hippocampal memory function in rats and humans. Nature. 379:1996;255-257.
12. Coull J.T. Pharmacological manipulations of the alpha 2-noradrenergic system. Effects on cognition. Drugs and Aging. 5:1994;116-126.
13. Coull J.T., Middleton H.C., Robbins T.W., Sahakian B.J. Contrasting effects of clonidine and diazepam on tests of working memory and planning. Psychopharmacology. 120:1995;311-321.
14. Drachman D.A., Noffsinger D., Sahakian B.J., Kurdziel S., Flemming P. Aging, memory, and the cholinergic system. A study of dichotic listening Neurobiol Aging. 1:1980;39-43.
15. Dunnett S.B., Barry J.E., Robbins T. The basal forebrain-cortical cholinergic system. Interpreting the functional consequences of excitotoxic lesions Trends Neurosci. 14:1991;494-501.
16. Goodwin G.M., Conway S.C., Peyro Saint Paul H., Glabus M., O'Carroll R.E., Ebmesier K.P. Executive function and uptake of 99mTc-exametazine shown by single photon emission tomography after oral idazoxan in probable Alzheimer-type dementia. Psychopharmacology. 131:1997;371-378.
17. Heindel W.C., Salmon D.P., Shults C.W., Walicke P.A., Butters N. Neuropsychological evidence for multiple implicit memory systems. A comparison of Alzheimer's, Huntington's, and Parkinson's disease patients J Neurosci. 9:1989;582-587.
18. Heindel W.C., Salmon D.P., Butters N. The biasing of weight judgments in Alzheimer's and Huntington's disease. A priming or programming phenomenon J Clin Exp Neuropsychol. 13:1991;189-203.
19. Jelicic M., Bonebakker A.E., Bonke B. Implicit memory performance of patients with Alzheimer's disease. A brief review Int Psychogeriatr. 7:1995;385-392.
20. Kopelman M.D., Corn T.H. Cholinergic "blockade" as a model for cholinergic depletion. Brain. 111:1988;1079-1110.
21. Leonard B.W., Amaral D.G., Squire L.R., Zola-Morgan S. Transient memory impairment in monkeys with bilateral lesions of the entorhinal cortex. J Neurosci. 15:1995;5637-5659.
22. Mair R.G., McEntee W.J. Cognitive enhancement in Korsakoff's psychosis by clonidine. A comparison with l-dopa and ephedrine Psychopharmacology. 88:1986;444-457.
23. Millner B (1964): Some effects of frontal lobectomy in man. In Warren JM, Akert K (eds), The Frontal Granular Cortex and Behavior. New York, McGraw-Hill, pp 313-331.
24. Moffoot A., O'Carroll R.E., Murray C., Dougall N., Ebmeier K., Goodwin G.M. Clonidine infusion increases uptake of 99m-Tc-exametazine in anterior cingulate cortex psychosis in Korsakoff psychosis. Psychological Medicine. 24:1994;53-61.
25. Mohr E., Schlegel J., Fabbrini G., Williams J., Mouradian M.M., Mann U.M., Claus J.J., Fedio P., Chase T.N. Clonidine treatment of Alzheimer's disease. Arch Neurol. 46:1989;376-378.
26. Owen A.M., Downes J.J., Sahakian B.J., Polkey C.E., Robbins T.W. Planning and spatial working memory following frontal lobe lesions in man. Neuropsychologia. 29:1990;993-1006.
27. Phelps E.A., Hyder F., Blamire A.M., Shulma R.G. FMRI of the prefrontal cortex during overt verbal fluency. NeuroReport. 8:1997;561-565.
28. Reinikainen K.J., Riekkinen P.J., Paljärvi L., Soininen H., Helkala E.-L., Jolkkonen J., Laakso M. Cholinergic deficit in Alzheimer's disease. A study based on CSF and autopsy data Neurochem Res. 13:1988;135-146.
29. Riekkinen M., Soininen H., Kuikka J., Laakso M., Helkala E.-L., Partanen J., Riekkinen P. Jr. Tetrahydroaminoacridine improves the recency effect in Alzheimer disease. Neuroscience. 83:1998;471-479.
30. Riekkinen P. Jr., Riekkinen M., Soininen H., Kuikka J., Laakso M., Riekkinen P. Sr. Frontal dysfunction blocks the therapeutic effect of THA on attention in Alzheimer's disease. NeuroReport. 8:1997;1845-1849. a.
31. Riekkinen P. Jr., Soininen H., Partanen J., Pääkkönen A., Helisalmi S., Riekkinen P. Sr. The ability of THA treatment to increase cortical alpha waves is related to apolipoprotein E genotype of Alzheimer disease patients. Psychopharmacology. 129:1997;285-288. b.
32. Robbins T.W., Elliott R., Sahakian B. Neuropsychology - dementia and affective disorders. Br Med Bull. 52:1996;627-643.
33. Rueckert L., Appollonio I., Grafman J., Jezzard P., Johnson R. Jr., Le Bihan D., Turner R. Magnetic resonance imaging functional activation of left frontal cortex during covert word production. J Neuroimaging. 4:1994;67-70.
34. Sahakian B.J., Owen A.M., Morant N.J., Eagger S.A., Boddington S., Crayton L., Crockford H.A., Crooks M., Hill K., Levy R. Further analysis of the cognitive effects of tetrahydroaminoacridine (THA) in Alzheimer's disease. Assessment of attentional and mnemonic function using CANTAB Psychopharmacology. 110:1993;395-401.
35. Salmon D.P., Butters N. Neurobiology of skill and habit learning. Curr Opin Neurobiol. 5:1995;184-190.
36. Schwartz B.L., Hashtroudi S., Herting R.L., Schwartz P., Deutsch S.I. d-Cycloserine enhances implicit memory in Alzheimer patients. Neurology. 46:1996;420-424.
37. Shimamura A.P., Salmon D.P., Squire L.R., Butters N. Memory dysfunction and word priming in dementia and amnesia. Behav Neurosci. 101:1987;347-351.
38. Squire L.R. Memory and Brain. 1987;Oxford, New York.
39. Whitehouse P., Price D.L., Struble R.G., Clark A.W., Coyle J.T., DeLong R.M. Alzheimer's disease and senile dementia. Loss of neuron in the basal forebrain Science. 215:1982;1237-1239.
40. Wilcock G.K., Esiri M.M. Plaques, tangles and dementia. A quantitative study J Neurol Sci. 56:1982;343-356.